Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety and Pharmacokinetics of Ricolinostat (NCT05193851) | Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. | 2022-01-12 |
| A Study to Investigate the Safety and Efficacy of Ricolinostat (NCT05229042) | Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. | 2022-01-01 |
| Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPN (NCT05133947) | Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. | 2021-10-12 |
Track Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.